| abstract |
The present invention relates to heteroaryl compounds as MEK inhibitors. Such compounds include heteroaryl compounds of formula (I), pharmaceutically acceptable salts thereof, combinations with appropriate drugs, and pharmaceutical compositions thereof. The present invention also includes methods of preparing the compounds and methods of using the compounds in therapeutic methods. The compound described herein is a compound of the following formula (I). |